Quality in Clinical Trials

Level 2

  • 1

    Module 1: Quality Assurance

    • slide 2_1

    • slide 3

    • slide 4_1

    • slide 5

    • slide 6

    • slide 7

    • slide 8

    • slide 9_1

    • Knowledge Checkpoints 01

    • slide 10_1

    • slide 11

    • slide 12_1

    • slide 13

    • slide 14

    • slide 15

    • slide 16

    • Knowledge Checkpoints 02

    • slide 17

    • slide 18

    • slide 19

    • slide 20

    • slide 21

    • Knowledge Checkpoints 03

    • slide 22_1
  • 2

    Module 2: Audit and Inspection (including fraud)

    • slide 2

    • slide 3_1

    • slide 4

    • slide 5_1

    • slide 6

    • slide 7_1

    • slide 8_1

    • Knowledge Checkpoints 01

    • slide 9

    • slide 10

    • slide 11

    • slide 12

    • slide 13_1

    • slide 14

    • slide 15

    • slide 16_1

    • Knowledge Checkpoints 02

    • slide 17_1

    • slide 18

    • slide 19

    • slide 20

    • slide 21_1

    • slide 22

    • slide 23

    • slide 24

    • Knowledge Checkpoints 03

    • slide 25_1
  • 3

    Module 3: Fraud detection and management

    • Module 3: Fraud detection and management

Instructor

Chief Operating Officer

Dr Tina Barton

Dr. Tina Barton, Chief Operating Officer of eMQT, is a drug development specialist with over 40 years’ experience, working in partnership to lead for success as a customer-focused senior leader. During this time Dr. Barton has invested in training for the future – through team leadership, individual mentoring and training thereby sharing knowledge and developing professionals. Through her role at the Institute of Clinical Research she continues to support and lead training activities. With a passion for transformation, Dr. Barton drove the embracement of Central Eastern European countries and now is focused on the inclusion of Sub-Saharan Africa into clinical development – bringing the miracle of development of new medicines to emerging markets and new patients. Dr. Barton holds a BSc, PhD and MBA alongside over 50 academic publications and is an Honorary Fellow, and Board Member of the Institute of Clinical Research.